Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes

NCT01194882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: HUMAN INSULIN (BIOSYNTHETIC)
DRUG: Insuplant

Sponsor

Sanofi